Icon announces that Melton Affrime has been appointed to the position of senior vice president, global clinical pharmacology
Melton Affrime comes to Icon with over 23 years of demonstrated success in global pharmaceutical development.
In his new role he will take global responsibility for Icon Development Solutions clinical pharmacology activities.
Thomas Frey, president, Icon Development Solutions commented: "We are delighted Melton has joined the Icon team.
"He brings a wealth of experience across multiple therapeutic areas and technical disciplines, which will prove invaluable in supporting the continued growth and development of our clinical pharmacology services." Affrime was a co-founder of the Hahnemann clinical pharmacology research unit and was most recently global head, profiling, clinical pharmacology at Novartis Pharmaceuticals.
Prior to this he was vice president of clinical pharmacology at Schering-Plough research institute and has held a number of other senior positions in both commercial and medical organizations.
He received his PharmD degree from the Philadelphia College of Pharmacy and Science.
Commenting on his appointment, Affrime said: "I am delighted to be joining Icon, with its reputation for delivering high quality clinical pharmacology programmes.
"I look forward to sharing the experience I have gained in early drug development with Icon's extensive client base."
